Ventures & Companies | Andrew Hillman

Targeted Osmotic Lysis (TOL) is investigational. It has not been approved by the FDA for any indication. It is not available as a treatment. Exosome and mesenchymal stem cell-derived extracellular vesicle products are not approved by the FDA for any indication. Content on this page is educational and describes published scientific literature. It does not describe an available treatment, it does not report results in patients, and it does not offer access to any therapy.

Companies co-founded.

Hillman Ventures

Founded 1995. Dallas. Private family office investing personal capital in FDA-regulated frontier biotech. Active.

Affinity Healthcare Systems Inc

2007 to 2010. Co-founder. FDA-regulated specialty healthcare services. Exited to Dynacq Healthcare (NASDAQ: DYII).

PPM Rehabilitation

2011 to 2016. Co-founder. Rehabilitation services platform. Exited to Next Health.

Advanced Total Management

2012 to 2017. Co-founder. Pharmaceutical wholesale distribution. Exited to Next Health (LinkedIn).

Infinity Toxicology LLC

2012 to 2020. Co-founder. CLIA Highly Complex toxicology laboratory. Exited to Critical Healthcare Ltd, UK.

Apothecary Shop Pharmacy

2007 to 2014. Co-founder. Specialty pharmacy services. Exited to Pharma Holdings U.S.

Dallas Claims Assistance

1998 to 2005. Co-founder. Healthcare claims processing. Exited to The Alpha Group (TAG).

Current focus areas

Mesenchymal exosome biologics on the 351(a) BLA pathway. Targeted Osmotic Lysis for solid tumors with an academic medical foundation.

On the public record

Current and past companies.

Current versus past is labeled. Past means exited or sold. Ownership percentages are not stated. Source: andrewhillmanrecord.com.

Some names above already appear as cards. This list is the complete record set.

CURRENT: Principal, Hillman Ventures. A Dallas biotech family office.
PAST · Hospitals: Victory Healthcare / Victory Medical Center facilities. Past ownership. Former Victory Hospitals were later acquired by Nobilis Health (2015).
PAST · Hospitals: Dynacq Healthcare (NASDAQ: DYII; Fintel DYII, Dividend.com, Houston Chronicle Business Wire reprint) / Vista Hospital / SSHA. Past hospital ownership.
PAST · Devices: Bone Solutions, Inc., Southlake, Texas. April 2016–November 2021.
PAST · Pharmacies (sold or exited): The Apothecary Shop (Dallas; sold; now Executive Health, LLC); Progressive Pharma / Altus Pharmacy (Houston); Super Frisco Pharmacy / Centennial / Frisco Pharmacy (Frisco).
PAST · Laboratories (exited): Gulf Coast Toxicology; Central Texas Toxicology; East Texas Toxicology; National Toxicology; Digestive Laboratories; Quality Lab Partners.
PAST · Anesthesia and staffing (exited): Prime Anesthesia Staffing; First Assisting Specialists of Texas; L2 Surgical.
PAST · Holding and management (exited): RHZ, LLC; Optimized, Inc.; Advanced Total Management; Energized, LLC; Forge Realty Partners.